Transcriptome analysis of the effects of chitosan on the hyperlipidemia and oxidative stress in high-fat diet fed mice

• Published in: International journal of biological macromolecules Vol. 102; pp. 104 - 110
• Main Authors: Wang, Bin, Zhang, Sicong, Wang, Xiaoya, Yang, Shuo, Jiang, Qixing, Xu, Yanshun, Xia, Wenshui
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.09.2017
• Subjects: Adipose Tissue - drug effects; Adipose Tissue - pathology; Animals; Body Weight - drug effects; Chitosan; Chitosan - pharmacology; Diet, High-Fat - adverse effects; Epididymis - pathology; Gene Expression Profiling; Gene Ontology; High-fat diet; Hyperlipidemias - drug therapy; Hyperlipidemias - etiology; Hyperlipidemias - genetics; Hyperlipidemias - metabolism; Lipids - blood; Liver - drug effects; Liver - metabolism; Liver - pathology; Male; Mice; Mice, Inbred C57BL; Organ Size - drug effects; Oxidative Stress - drug effects; Transcriptome analysis; Transcriptome analysis; High-fat diet; Chitosan
• ISSN: 0141-8130; 1879-0003
• DOI: 10.1016/j.ijbiomac.2017.03.187

•High-fat diet induced hyperlipidemia in mice.•Chitosan attenuated hyperlipidemia and chronic oxidative stress in the HFD mice.•Chitosan decreased Mups, Lcn2, Gstm3 and CYP2E1 expressions of HFD mice. Transcriptome analysis was performed to investigate the alterations in gene expression after chitosan (CS) treatment on the liver of mice fed with high-fat diet (HFD). The results showed that the body weight, the liver weight and the epididymal fat mass of HFD mice, which were 62.98%, 46.51% and 239.37%, respectively, higher than those of control mice, could be significantly decreased by chitosan supplementation. Also, high-fat diet increased both plasma lipid and liver lipid as compared with the control mice. Chitosan supplementation decreased the plasma lipid and liver lipid, increased the lipoprotein lipase (LPL) and hepatic lipase (HL) activity, increased T-AOC and decreased MDA in the liver and the epididymis adipose as compared with the HFD mice. Transcriptome analysis indicated that increased Mups, Lcn2, Gstm3 and CYP2E1 expressions clearly indicated HFD induced lipid metabolism disorder and oxidative damage. Especially, chitosan treatment decreased the Mup17 and Lcn2 expressions by 64.32% and 82.43% respectively as compared with those of HFD mice. These results indicated that chitosan possess the ability to improve the impairment of lipid metabolism as strongly associated with increased Mups expressions and gene expressions related to oxidative stress.